541 related articles for article (PubMed ID: 19582702)
1. Decreased serum levels of kisspeptin in early pregnancy are associated with intra-uterine growth restriction and pre-eclampsia.
Armstrong RA; Reynolds RM; Leask R; Shearing CH; Calder AA; Riley SC
Prenat Diagn; 2009 Oct; 29(10):982-5. PubMed ID: 19582702
[TBL] [Abstract][Full Text] [Related]
2. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
Davidson EJ; Riley SC; Roberts SA; Shearing CH; Groome NP; Martin CW
BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935
[TBL] [Abstract][Full Text] [Related]
3. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation.
Wathén KA; Ylikorkala O; Andersson S; Alfthan H; Stenman UH; Vuorela P
Acta Obstet Gynecol Scand; 2009; 88(5):593-8. PubMed ID: 19308751
[TBL] [Abstract][Full Text] [Related]
4. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers.
Wald NJ; Morris JK; Ibison J; Wu T; George LM
Prenat Diagn; 2006 Jun; 26(6):559-64. PubMed ID: 16700087
[TBL] [Abstract][Full Text] [Related]
5. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
Spencer K; Cowans NJ; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of adiponectin and leptin at 23-25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction.
Savvidou MD; Sotiriadis A; Kaihura C; Nicolaides KH; Sattar N
Clin Sci (Lond); 2008 Oct; 115(7):219-24. PubMed ID: 18211260
[TBL] [Abstract][Full Text] [Related]
7. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
Chafetz I; Kuhnreich I; Sammar M; Tal Y; Gibor Y; Meiri H; Cuckle H; Wolf M
Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748
[TBL] [Abstract][Full Text] [Related]
8. First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction.
Ong CY; Liao AW; Munim S; Spencer K; Nicolaides KH
J Matern Fetal Neonatal Med; 2004 Mar; 15(3):176-80. PubMed ID: 15280143
[TBL] [Abstract][Full Text] [Related]
9. Second trimester serum free beta human chorionic gonadotrophin levels as a predictor of pre-eclampsia.
Luckas M; Hawe J; Meekins J; Neilson J; Walkinshaw S
Acta Obstet Gynecol Scand; 1998 Apr; 77(4):381-4. PubMed ID: 9598944
[TBL] [Abstract][Full Text] [Related]
10. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia.
Spencer K; Cowans NJ; Nicolaides KH
Prenat Diagn; 2008 Jan; 28(1):7-10. PubMed ID: 18000943
[TBL] [Abstract][Full Text] [Related]
11. Correlation between second trimester maternal serum inhibin-A and human chorionic gonadotrophin for the prediction of pre-eclampsia.
Aquilina J; Maplethorpe R; Ellis P; Harrington K
Placenta; 2000; 21(5-6):487-92. PubMed ID: 10940198
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum activin A levels in association with intrauterine fetal growth restriction.
Wallace EM; Schneider-Kolsky ME; Edwards A; Baker L; Jenkin G
BJOG; 2003 Mar; 110(3):306-10. PubMed ID: 12628273
[TBL] [Abstract][Full Text] [Related]
13. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction.
Cetin I; Cozzi V; Pasqualini F; Nebuloni M; Garlanda C; Vago L; Pardi G; Mantovani A
Am J Obstet Gynecol; 2006 May; 194(5):1347-53. PubMed ID: 16647920
[TBL] [Abstract][Full Text] [Related]
14. Decreased plasma levels of metastin in early pregnancy are associated with small for gestational age neonates.
Smets EM; Deurloo KL; Go AT; van Vugt JM; Blankenstein MA; Oudejans CB
Prenat Diagn; 2008 Apr; 28(4):299-303. PubMed ID: 18317999
[TBL] [Abstract][Full Text] [Related]
15. Serum markers of macrophage activation in pre-eclampsia: no predictive value of soluble CD163 and neopterin.
Kronborg CS; Knudsen UB; Moestrup SK; Allen J; Vittinghus E; Møller HJ
Acta Obstet Gynecol Scand; 2007; 86(9):1041-6. PubMed ID: 17712642
[TBL] [Abstract][Full Text] [Related]
16. Second-trimester sex hormone-binding globulin and subsequent development of pre-eclampsia.
Yu CK; Papageorghiou AT; Bindra R; Spencer K; Nicolaides KH
J Matern Fetal Neonatal Med; 2004 Sep; 16(3):158-62. PubMed ID: 15590441
[TBL] [Abstract][Full Text] [Related]
17. Association between birth weight and first-trimester free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A.
Canini S; Prefumo F; Pastorino D; Crocetti L; Afflitto CG; Venturini PL; De Biasio P
Fertil Steril; 2008 Jan; 89(1):174-8. PubMed ID: 17509577
[TBL] [Abstract][Full Text] [Related]
18. Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity.
Kang JH; Farina A; Park JH; Kim SH; Kim JY; Rizzo N; Elmakky A; Jun HS; Hahn WB; Cha DH
Prenat Diagn; 2008 Aug; 28(8):704-9. PubMed ID: 18655226
[TBL] [Abstract][Full Text] [Related]
19. sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by pre-eclampsia with and without intrauterine growth retardation.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
Gynecol Obstet Invest; 2007; 64(1):8-13. PubMed ID: 17199090
[TBL] [Abstract][Full Text] [Related]
20. Early onset preeclampsia and second trimester serum markers.
Lambert-Messerlian GM; Palomaki GE; Neveux LM; Chien E; Friedman A; Rosene-Montella K; Hayes M; Canick JA
Prenat Diagn; 2009 Dec; 29(12):1109-17. PubMed ID: 19842088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
